Ibrutinib modulates CD19 expression and improves efficacy of CD19-CAR T cells in B-cell lymphoma models
Sisi Wang, Alberto J. Arribas, Chiara Tarantelli, Elisa Civanelli, Guangyu Zhou, Pragallabh Purwar, Amandine Pradier, Astrid Melotti, Francesca Guidetti, Yara Hajj Younes, Lodovico Terzi di Bergamo, Luciano Cascione, Sara Napoli, Emanuele Zucca, Elena Sotillo, , Francesco Bertoni
The paper shows ibrutinib increases CD19 expression in B-cell lymphoma models, improving the effectiveness of CD19-CAR T cells.
bioRxiv · May 26, 2026 · PreprintImmunology